Sussex Medical Centre Limited

Contents

Statement of financial position	1
Notes to the Financial Statements	2 to 4

Sussex Medical Centre Limited

(Registration number: 5976812)
Statement of financial position as at 31 March 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	300	375
Investments	5	617,684	617,684
		617,984	618,059
Current assets
Debtors	6	103,555	95,218
Cash at bank and in hand		73,463	61,201
		177,018	156,419
Creditors: Amounts falling due within one year	7	(34,360)	(14,920)
Net current assets		142,658	141,499
Net assets		760,642	759,558
Capital and reserves
Called up share capital	8	755	755
Share premium reserve		756,243	756,243
Retained earnings		3,644	2,560
Shareholders' funds		760,642	759,558

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 12 December 2025 and signed on its behalf by:
 

......................................... Mrs M Shoai-Naini Director

Sussex Medical Centre Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

1	General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
10 Clive Avenue
Goring by Sea
West Sussex
BN12 4SG

These financial statements were authorised for issue by the Board on 12 December 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant and machinery	20 % reducing balance
Fixtures, fittings & equipment	20 % reducing balance
Office equipment	33 % reducing balance

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Sussex Medical Centre Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2024 - 4).

4	Tangible assets

	Furniture, fittings and equipment  £	Total £
Cost or valuation
At 1 April 2024	15,191	15,191
At 31 March 2025	15,191	15,191
Depreciation
At 1 April 2024	14,816	14,816
Charge for the year	75	75
At 31 March 2025	14,891	14,891
Carrying amount
At 31 March 2025	300	300
At 31 March 2024	375	375

Sussex Medical Centre Limited

Notes to the Financial Statements for the Year Ended 31 March 2025

5	Investments

	2025 £	2024 £
Investments in subsidiaries	617,684	617,684

6

Debtors

Current	2025 £	2024 £
Amounts due from subsidiary	103,555	95,218
	103,555	95,218

7

Creditors

Creditors: amounts falling due within one year

	2025 £	2024 £
Due within one year
Accruals and deferred income	1,920	1,920
Other creditors	32,440	13,000
	34,360	14,920